|
(S)-3-(1-(9H-purin-6-ylamino)ethyl)-8-chloro-2-phenylisoquinolin-1(2H)-one |
|---|---|
| Trade Name | |
| Orphan Indication | Follicular lymphoma |
| USA Market Approval | USA |
| USA Designation Date | 2013-08-01 00:00:00 |
| Sponsor | Verastem, Inc.;117 Kendrick Street, Suite 500;Needham, Massachusetts, 02494 |
